Emerging Pharmaceutical Industry Strategies: Transparency, Privacy and COI Concerns. Jennifer L. Reck, Policy Analyst, Prescription Policy Choices. NLARx Meeting Washington, DC December 8, 2008. Prescription Policy Choices.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Jennifer L. Reck,
Prescription Policy Choices
December 8, 2008
Worthy endeavors – but appropriate roles for pharma?
Will pharma blur the line between marketing and clinical care the way it has blurred the line between marketing and medical research? And between marketing and education?